Status:
WITHDRAWN
STRENGTH Expansion
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Esophageal Cancer
Gastroesophageal Junction Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Patients seen in the EGMDC (Esophageal and Gastric Multidisciplinary Clinic) for treatment planning who are recommended to receive neoadjuvant treatment followed by surgery at UCCC Metro will be offer...
Detailed Description
Patients with esophageal (EC) and gastroesophageal junction (GEJC) cancers who are seen in the Esophageal and Gastric Multidisciplinary Clinic (EGMDC) for treatment planning and are recommended to rec...
Eligibility Criteria
Inclusion
- Provision to sign and date the consent form
- Age ≥ 18 years
- Receiving treatment according to the STRENGTH pathway
- Diagnosed with esophageal(EC)/gastroesophageal junction cancer(GEJC) stage IB-IIIB
- Planning to receive neoadjuvant treatment followed by surgery at University of Colorado Cancer Center (UCCC) Metro
- Ability to complete surveys online via an emailed REDCap survey link if unable to complete in person
Exclusion
- Inability to read English and complete questionnaires independently
- Per the investigator, unable to comply with study criteria or assessments
- Inability to receive and complete REDCap survey online
Key Trial Info
Start Date :
August 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 16 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04520867
Start Date
August 6 2020
End Date
November 16 2021
Last Update
November 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Hospital
Aurora, Colorado, United States, 80045